Combined regression score predicts outcome after neoadjuvant treatment of oesophageal cancer.

Alexander I DamanakisF GebauerA StapperH A SchlößerM GhadimiThomas SchmidtL M SchiffmannH FuchsT ZanderA QuaasC J BrunsWolfgang Schröder

Published in: British journal of cancer (2023)

Histopathologic regression and nodal status should be combined for estimating AC and SCC prognosis. Poor survival in the high-risk group highlights need for adjuvant therapy.

Keyphrases

lymph node
papillary thyroid
rectal cancer
neoadjuvant chemotherapy
locally advanced
squamous cell
lymph node metastasis
young adults